Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting 5,000,000 target

The Pediatric Anesthesia Quality Improvement Project

The Society for Pediatric Anesthesia

NCT00674388

Recruiting 2,000,000 target

Helix Research Network

Helix

NCT06057181

Recruiting 100,000 target

US National OCS Liver Perfusion (OLP) Registry

TransMedics

NCT05940857

Recruiting 30,000 target

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Mayo Clinic

NCT06271291

Recruiting NA 14,400 target

The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

Boston Children's Hospital

NCT05591066

Recruiting Phase 3 11,000 target

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Boehringer Ingelheim

NCT06531824

Recruiting 10,000 target

Tracking Results of Ablations to Combat AF Registry Generation 2

AtriCure

NCT05111015

Recruiting 10,000 target

Innovations in Genicular Outcomes Registry

Pacira Pharmaceuticals

NCT05495334

Recruiting NA 8,100 target

Behavioral Economic & Staffing Strategies in the ICU

University of Nebraska

NCT06184945

Recruiting 7,000 target

Quality of Pediatric Resuscitation in a Multicenter Collaborative

Children's Hospital of Philadelphia

NCT02708134

Recruiting NA 6,254 target

The GUARDIAN Trial

The University of Texas Health Science Center, Houston

NCT04884802

Recruiting NA 6,250 target

Platform of Randomized Adaptive Clinical Trials in Critical Illness

University Health Network, Toronto

NCT05440851

Recruiting 5,000 target

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

The University of Texas Health Science Center, Houston

NCT04005976

Recruiting 5,000 target

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

The University of Texas Health Science Center, Houston

NCT05685745

Recruiting NA 4,700 target

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

VA Office of Research and Development

NCT05486572

Recruiting Phase 3 4,000 target

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Vaxcyte

NCT07284654

Recruiting 3,784 target

Abbott Vascular Medical Device Registry

Abbott Medical Devices

NCT04573660

Recruiting NA 3,000 target

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

Children's Hospital of Philadelphia

NCT06085326

Recruiting 3,000 target

Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science

Columbia University

NCT00950118

Recruiting NA 2,634 target

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

University of Alabama at Birmingham

NCT06455085

Recruiting Phase 3 2,540 target

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

VA Office of Research and Development

NCT05931276

Recruiting NA 2,300 target

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Weill Medical College of Cornell University

NCT04124120

Recruiting Phase 4 2,000 target

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

University of Rochester

NCT06964464

Recruiting 2,000 target

ASSESS ALL ALS Study

St. Joseph's Hospital and Medical Center, Phoenix

NCT06578195

Recruiting 2,000 target

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Arkansas Children's Hospital Research Institute

NCT05550298

Recruiting NA 2,000 target

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

Karius

NCT07110636

Recruiting NA 1,920 target

An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)

University of Maryland, College Park

NCT06058455

Recruiting Phase 3 1,800 target

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Massachusetts General Hospital

NCT06192615

Recruiting Phase 4 1,710 target

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Insud Pharma

NCT05303636

Recruiting 1,500 target

An International Observational Study of Adults With Acute Infection

University of Minnesota

NCT07069400

Recruiting Phase 1 1,405 target

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

ModernaTX

NCT05992935

Recruiting Phase 3 1,300 target

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Vaxcyte

NCT07365826

Recruiting 1,260 target

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Children's Hospital Los Angeles

NCT06690801

Recruiting Phase 2 1,260 target

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

BioNTech SE

NCT06712316

Recruiting 1,250 target

Blood Markers of Early Pancreas Cancer

University of Nebraska

NCT03568630

Recruiting NA 1,200 target

A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans

University of Nebraska

NCT05903885

Recruiting NA 1,200 target

The PEERLESS II Study

Inari Medical

NCT06055920

Recruiting NA 1,200 target

Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure

Analog Device

NCT05650541

Recruiting Phase 1 1,130 target

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Revolution Medicines

NCT06445062

Recruiting NA 1,100 target

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Population Health Research Institute

NCT04743765

Recruiting Phase 3 1,100 target

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

AstraZeneca

NCT07218809

Recruiting Phase 4 1,094 target

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

ModernaTX

NCT06585241

Recruiting 1,065 target

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Merck Sharp & Dohme

NCT04165798

Recruiting 1,051 target

A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development

Ipsen

NCT06055725

Recruiting NA 1,024 target

iAmHealthy Clinical Practice Guideline (CPG)

University of Kansas Medical Center

NCT06888011

Recruiting NA 1,000 target

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

University of Nebraska

NCT05864118

Recruiting 1,000 target

A Registry for People With T-cell Lymphoma

Memorial Sloan Kettering Cancer Center

NCT05978141

Recruiting 1,000 target

BBD Longitudinal Study of Osteogenesis Imperfecta

Baylor College of Medicine

NCT02432625

Recruiting Phase 4 1,000 target

Secukinumab Open Label Roll-over Extension Protocol

Novartis Pharmaceuticals

NCT04638647

Recruiting Phase 2 956 target

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

BicycleTx Limited

NCT06225596

Recruiting Phase 3 864 target

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

GlaxoSmithKline

NCT06256588

Recruiting Phase 2 854 target

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

AbbVie

NCT07005102

Recruiting Phase 4 850 target

Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

Nebraska Methodist Health System

NCT07023003

Recruiting Phase 3 830 target

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

AstraZeneca

NCT06868277

Recruiting Phase 2 827 target

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Gilead Sciences

NCT03547973

Recruiting Phase 3 815 target

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Merck Sharp & Dohme

NCT07218029

Recruiting Phase 3 800 target

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Hoffmann-La Roche

NCT07170150

Recruiting Phase 2 800 target

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05917522

Recruiting Phase 3 800 target

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Janssen Research & Development

NCT07225946

Recruiting Phase 4 787 target

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Eli Lilly and Company

NCT06876649

Recruiting NA 780 target

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

BrioHealth Solutions

NCT06310031

Recruiting Phase 3 770 target

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Merck Sharp & Dohme

NCT06824467

Recruiting Phase 3 750 target

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Hoffmann-La Roche

NCT06094010

Recruiting Phase 3 723 target

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Pfizer

NCT06641466

Recruiting Phase 3 720 target

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Arcus Biosciences

NCT07011719

Recruiting Phase 3 720 target

A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

Bavarian Nordic

NCT07003984

Recruiting Phase 3 720 target

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination

Vaxcyte

NCT07425392

Recruiting Phase 4 700 target

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Novartis Pharmaceuticals

NCT05803941

Recruiting Phase 2 690 target

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Bristol-Myers Squibb

NCT07221149

Recruiting Phase 3 675 target

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

AbbVie

NCT06461897

Recruiting Phase 3 663 target

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Janssen Research & Development

NCT07164443

Recruiting Phase 3 641 target

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Janssen Research & Development

NCT06319820

Recruiting Phase 2 630 target

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

AstraZeneca

NCT05061550

Recruiting NA 625 target

Comprehensive Outcomes for After Cancer Health

Pack Health

NCT05349227

Recruiting Phase 3 621 target

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

BioNTech SE

NCT06712355

Recruiting Phase 1 616 target

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Revolution Medicines

NCT06162221

Recruiting 600 target

PREVENT ALL ALS Study

St. Joseph's Hospital and Medical Center, Phoenix

NCT06581861

Recruiting Phase 2 600 target

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

BioAegis Therapeutics

NCT05947955

Recruiting Phase 4 600 target

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Nebraska Methodist Health System

NCT05309460

Recruiting Phase 2 590 target

A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Bristol-Myers Squibb

NCT07063745

Recruiting 580 target

PULSED AF Post-Approval Study

Medtronic Cardiac Ablation Solutions

NCT06578104

Recruiting 560 target

Project Mountain - Comparing SpO2 and SaO2 for Accuracy

Philips Clinical & Medical Affairs Global

NCT06372106

Recruiting Phase 3 556 target

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Merck Sharp & Dohme

NCT06074588

Recruiting Phase 3 550 target

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Shanghai Henlius Biotech

NCT06532006

Recruiting Phase 3 540 target

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Daiichi Sankyo

NCT06203210

Recruiting Phase 3 520 target

Neoadjuvant Darovasertib in Primary Uveal Melanoma

IDEAYA Biosciences

NCT07015190

Recruiting Phase 2 512 target

Preventing Injured Knees From osteoArthritis: Severity Outcomes

Brigham and Women's Hospital

NCT06096259

Recruiting Phase 1 512 target

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

AbbVie

NCT05005403

Recruiting NA 500 target

Encore PFO Closure Device - The PerFOrm Trial

Encore Medical

NCT05537753

Recruiting 500 target

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Urotronic

NCT06560476

Recruiting Phase 3 500 target

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Janssen Research & Development

NCT07276399

Recruiting Phase 3 500 target

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Prilenia

NCT07322003

Recruiting Phase 3 500 target

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Astellas Pharma Global Development

NCT06901531

Recruiting Phase 1 499 target

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

TopAlliance Biosciences

NCT04137900

Recruiting Phase 2 492 target

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

DualityBio

NCT06953089

Recruiting Phase 3 480 target

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Dianthus Therapeutics

NCT06858579

Recruiting NA 477 target

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

C. R. Bard

NCT03911700

Recruiting Phase 3 477 target

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Merck Sharp & Dohme

NCT06997497

Recruiting Phase 3 466 target

A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

Paradigm Biopharmaceuticals

NCT06917404

Recruiting Phase 3 450 target

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

Eli Lilly and Company

NCT06339008

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →